Table 1 Patients characteristics and interventions

Number of patients

28

49

77

Male

19 (67.9%)

20 (40.8%)

39 (50.6%)

Female

9 (32.1%)

29 (59.2%)

38 (49.4%)

Height [m]

1.73 ± 0.076

1.68 ± 0.077

1.70 ± 0.083

Weight [kg]

75.4 ± 14.1

70.21 ± 17.2

72.2 ± 16.2

Age [years]

60.2 ± 11.8

61.1 ± 15.0

60.7 ± 13.9

APACHE-II

23.5 ± 5.6

22.3 ± 8.6

22.7 ± 7.6

ARDS

8/28 (28.6%)

17/49 (34.7%)

25/77 (32.5%)

Liver Disease

8 /28(28.6%)

10/49 (20.4%)

18/77 (23.4%)

Gastric Disease

3/28 (10.7%)

3/49 (6.1%)

6/77 (7.8%)

Sepsis

3/28 (10.7%)

11/49 (22.4%)

14/77 (18.2%)

Cardiogenic Shock

3/28 (10.7%)

4/49 (8.2%)

7/77 (9.1%)

Affection of the central nervous system

3/28 (10.7%)

4/49 (8.2%)

7/77 (9.1%)

Mechanical ventilation

39/55 (70.9%)

33/67 (49.3%)

72/122 (59.0%)

Use of catecholamines

30/56 (53.6%)

31/67 (46.3%)

61/123 (49.6%)

Change in catecholamine dose

29/56 (51.8%)

29/67 (43.3%)

58/123 (47.2%)

Terlipressin

4/56 (7.1%)

5/67 (7.5%)

9/123 (7.3%)

Change in Terlipressin

3/56 (5.4%)

3/67 (4.5%)

6/123 (4.9%)

Other vasoactive drug (Clonidin…)

10/56 (17.9%)

1/67 (1.5%)

11/123 (8.9%)

Change in other vasoactive drug

10/56 (17.9%)

1/67 (1.5%)

11/123 (8.9%)

Any vasoactive drug

38/56 (67.9%)

33/67 (49.3%)

71/123 (57.7%)

Change in any vasoactive drug

37/56 (66.1%)

31/67 (46.3%)

68/123 (55.3%)

Renal replacement therapy (RRT)

12/56 (21.4%)

7/67 (10.4%)

19/123 (15.4%)

Change in RRT

11/56 (19.6%)

7/67 (10.4%)

18/123 (14.6%)

Change in positioning (prone/supine)

1/56 (1.8%)

3/67 (4.5%)

4/123 (3.3%)

Pleural puncture

1/56 (1.8%)

2/67 (3.0%)

3/123 (2.4%)

Transfusion

5/56 (8.9%)

2/67 (3.0%)

7/123 (5.7%)

Cardioversion

1/56 (1.8%)

1/67 (1.5%)

2/123 (1.6%)

Change in heart rhythm

4/56 (7.1%)

3/67 (4.5%)

7 /123 (5.7%)

Change in ventilation mode

10/56 (17.9%)

1/67 (1.5%)

11/123 (8.9%)